Citrus Sinensis ID: 038705


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVSD
cHHHHHHHHHHHHHcccccEEccccccEEEcHHHHHHHHHHHHcccEEcccEEcccccccccccEEEEEEEEcccccccccccccccccccEEEcccccccccccHHHHHHHHHHHcccccEEEEEccccccccccccccccccccEEcccccccccccccccccccccEEEcccccccHHHHHcccccccccEEEEccccccccccccccccccccccccEEEcccccccHHHcccccccccEEEEEcccccccHHHHHHHccccccccccEEEEEcccccccccccHHHHccccccccccccccEEEEEEccccccccccccccccEEEEEEEccccccccccccccccccEEEccccccEEEEcccccccccccccccccEEEEcccccccccccccccccccccccccEEEEccccccccccccccccccEEEEEccccccccccccccccEEEEccccccccccccccccccccHHHHHHHHHcccccccccccccEEEEEcccccccccccccccccccEEEEEcccccccccccccccccccccEEEEEcccccEEccccccccccccEEEEEcccccccccccccccccccEEEEccccccccHHccccccccccEEEEEcccccccccccccccccccEEEEEccccccccccccccccccEEEEEEEccccccccccccccccccEEEEEccccccccccccccccccEEEEEcccccccccccccccccccccEEEEEEcccccEEccccccccccccccEEEEEcccccccccccccccccccEEEEEccccccccccccccccccEEEEEccHHHHHHHcccccccccccccccEEEEccEEEEEccc
ccHHHHHHHHHHHHHHHHccccccccEEEHHHHHHHHHHHHHccEEEEEHHHccccccccccccEEEEEEEcccccccccccHHHHHHHccEEEccccccccccccHHHHHHHHHHHHccEEEEEEEcccccccccccccccHHEEEEEccccccccccHHHHHHHHHHHHHHcccHHHHHccHHHHccccccEEEcccccccccccccccccccccEEcEEEEcccccccHHHHHHHHHcccEEEEEcccccccHHHHHHHHHcccccccEEEEEEccccccccccHHHHHHHHHHccccccccEEEEEccccccccccccccccHccEEEEEcccccccccccccccccccEEEEcccccEEEccHHHcccccccccccccEEEccccHHHHHHccccccccccccccHHEEEEccccHHHcccccccccccEEEEcccccHcccccccccccEEEEEccccEEcccccccHHHHHHHHHcccccccccccccccccccEEEEccccccccccccccccccccEEEEcccccHcccccHccccccccHcEEEEccccccccccccccccccccEEEEccccccccccccccccccccEEEEccccccccccccccccccccEEEEcccccHccccccccccccccEEEEccccccccccccccccccccEEEEcccHHHccccccccccccccEEEEcccccccccccccccccccEEEEcccHHHHcccHHccccccccccEEEEcccccccccccccccccccccccEEEEcccccHHcccHHccccccccEEEEcccccHcccccccccccccEEEEcccHHHHHHHHcccccccccEEEccEEEEccEEEEEccc
medlgrkffrdlhaksffqqsscdtsrFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPlvlsntwsgkaYLAHSVLYMLFKLQRLRVLSLRgysifhvpssigdlkhlqyldlsetKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSliklhhlknsNVKALEEMPKGIGNLTHLLTLSRfvvgkdvgsgLRTLKLLKHLQgtldisklenvkdaSEAKEAQLIEKRNLLRLLLEWtsstsddpmehENVTLMLdglkphrnleeltirgyggttfptwmgdssfANLVLLRFEgchrctslpsvgqlpllkHLFIIEMTSVKmvgsefygnhcsvpfpsletlCFQDIQewegwiphgsgkevnvfpqlrelsligcpklqgrlpeCLSSLERLVVRGCEQLTVLVSSLPklckleiggckgmawrstndvnrccPQLLWLIAEeeqdqqqpvfpcslqylelsQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIddcasltsllpknelpatLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERldnnssleavKISYCENLIVLPDGLLKLNHLQEIFishcpnlisfpdggflsstLTKLWIYECEKLkalpngmhnltslqeleigdlpsmvyfpedgfptnlhslEIRDMKMWKSLIeweplnrftslrrlsihgcqdmvsfpqdnigmmlpasLTKLEIVRFSNLEYLSSvgeslpsleclilddcpklryfpdkglppsllqlhisncplieescrkdggqywhlisdipcvyinfrcvfdvsd
MEDLGRKFFrdlhaksffqqsscDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVpssigdlkhlQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQgtldisklenvkdaSEAKEAQLIEKRNLLRLLLEWTsstsddpmehENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNlikeesiqssSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVSD
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNllrlllEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVSD
*******FFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLEN**********QLIEKRNLLRLLLEWT************VTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDV**
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLE*****RFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSD****HENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKE*********YTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIE**PLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDV**
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVSD
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVS*
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFKLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDxxxxxxxxxxxxxxxxxxxxxRNLLRLLLEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFDVSD
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query861 2.2.26 [Sep-21-2011]
Q9LRR51424 Putative disease resistan yes no 0.909 0.549 0.337 2e-86
Q9LRR41054 Putative disease resistan no no 0.621 0.507 0.323 2e-73
Q7XA42979 Putative disease resistan N/A no 0.571 0.502 0.312 3e-46
Q7XA39988 Putative disease resistan N/A no 0.579 0.505 0.295 8e-41
Q7XA40992 Putative disease resistan N/A no 0.600 0.521 0.307 1e-39
Q7XBQ9970 Disease resistance protei N/A no 0.578 0.513 0.296 5e-38
O23530 1301 Protein SUPPRESSOR OF npr no no 0.505 0.334 0.261 2e-12
Q38834852 Disease resistance RPP13- no no 0.371 0.375 0.273 5e-10
P23799630 Putative adenylate cyclas N/A no 0.281 0.384 0.296 8e-07
Q5ZLN0603 Leucine-rich repeat-conta yes no 0.182 0.260 0.341 1e-06
>sp|Q9LRR5|DRL21_ARATH Putative disease resistance protein At3g14460 OS=Arabidopsis thaliana GN=At3g14460 PE=3 SV=1 Back     alignment and function desciption
 Score =  321 bits (822), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 297/881 (33%), Positives = 417/881 (47%), Gaps = 98/881 (11%)

Query: 1    MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHR 60
            +ED+G  +  DL A+SFFQ+     + FVMH L+NDLA+  +GD  FR    LED     
Sbjct: 458  LEDIGNDYLGDLVAQSFFQRLDITMTSFVMHDLMNDLAKAVSGDFCFR----LEDDNIPE 513

Query: 61   FSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLY-MLFKL 119
                 RHFS+ R   D    F  +  A+ LRT LP   S T      L   VL  +L  L
Sbjct: 514  IPSTTRHFSFSRSQCDASVAFRSICGAEFLRTILPFN-SPTSLESLQLTEKVLNPLLNAL 572

Query: 120  QRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRL 179
              LR+LSL  Y I ++P S+  LK L+YLDLS TKIK LPE V  L NL TLLL NC  L
Sbjct: 573  SGLRILSLSHYQITNLPKSLKGLKLLRYLDLSSTKIKELPEFVCTLCNLQTLLLSNCRDL 632

Query: 180  KKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLK 239
              L  ++  LI L  L       L EMP GI  L  L  LS FV+G+  G+GL  LK L 
Sbjct: 633  TSLPKSIAELINLRLLDLVGT-PLVEMPPGIKKLRSLQKLSNFVIGRLSGAGLHELKELS 691

Query: 240  HLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTL-----M 294
            HL+GTL IS+L+NV  ASEAK+A L  K  L  L+L+WT   S       N        +
Sbjct: 692  HLRGTLRISELQNVAFASEAKDAGLKRKPFLDGLILKWTVKGSGFVPGSFNALACDQKEV 751

Query: 295  LDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKH 354
            L  L+PH +L+   I  Y G  FP W+GDSSF  +  +    C+ C SLP VGQLP LK+
Sbjct: 752  LRMLEPHPHLKTFCIESYQGGAFPKWLGDSSFFGITSVTLSSCNLCISLPPVGQLPSLKY 811

Query: 355  LFIIEMTSVKMVGSEFY---GNHCSVPFPSLETLCFQDIQEWEGWI-PHGSGKEVNVFPQ 410
            L I +   ++ VG +F+    N   VPF SL+ L F  +  W+ WI P     E  +FP 
Sbjct: 812  LSIEKFNILQKVGLDFFFGENNSRGVPFQSLQILKFYGMPRWDEWICPE---LEDGIFPC 868

Query: 411  LRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTV----------------LVSSLPKL 454
            L++L +  CP L+ + PE L S   + +  C    V                  +S+P +
Sbjct: 869  LQKLIIQRCPSLRKKFPEGLPSSTEVTISDCPLRAVSGGENSFRRSLTNIPESPASIPSM 928

Query: 455  CKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQY---LELSQCRYL 511
             + E+    G                      +     QP F  S Q     E++    L
Sbjct: 929  SRRELSSPTGNP------------------KSDASTSAQPGFASSSQSNDDNEVTSTSSL 970

Query: 512  VKLPQALLSLGFLREMEIYGNLIKE-ESIQSSSTRYTSLLEYLYIDDCASL-------TS 563
              LP+   +  F +     G+L ++ E     S RY+      YI D  S        TS
Sbjct: 971  SSLPKDRQTEDFDQYETQLGSLPQQFEEPAVISARYSG-----YISDIPSTLSPYMSRTS 1025

Query: 564  LL--PKNE---LPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVD------HCLKLKSL 612
            L+  PKNE   LP +  + + +     +  S   +  +A+K    D        LK+  +
Sbjct: 1026 LVPDPKNEGSILPGSSSYQYHQYGIKSSVPSPRSS--EAIKPSQYDDDETDMEYLKVTDI 1083

Query: 613  AERLDNNSSLEAVKISYCENLIVLPDGLLK-LNHLQEIFISHCPNLISFPDGGFLSSTLT 671
            +  ++   +L+++ I  C+ L  LP+ L +   +L E+ I  C +L SFP G    +TL 
Sbjct: 1084 SHLMELPQNLQSLHIDSCDGLTSLPENLTESYPNLHELLIIACHSLESFP-GSHPPTTLK 1142

Query: 672  KLWIYECEKLKALPN--GMHNLTSLQELEIG-DLPSMVYFPEDGFPTNLHSLEIRDMKMW 728
             L+I +C+KL    +     + + L+ L IG    ++V FP   FP  L SL IRD + +
Sbjct: 1143 TLYIRDCKKLNFTESLQPTRSYSQLEYLFIGSSCSNLVNFPLSLFP-KLRSLSIRDCESF 1201

Query: 729  KSL-IEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSV 787
            K+  I     +   +L  L I  C ++ +FPQ   G+  P    KL  +  SN + L ++
Sbjct: 1202 KTFSIHAGLGDDRIALESLEIRDCPNLETFPQG--GLPTP----KLSSMLLSNCKKLQAL 1255

Query: 788  GE---SLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNC 825
             E    L SL  L +  CP++   P  G P +L  L IS C
Sbjct: 1256 PEKLFGLTSLLSLFIIKCPEIETIPGGGFPSNLRTLCISLC 1296




Potential disease resistance protein.
Arabidopsis thaliana (taxid: 3702)
>sp|Q9LRR4|R13L1_ARATH Putative disease resistance RPP13-like protein 1 OS=Arabidopsis thaliana GN=RPPL1 PE=3 SV=1 Back     alignment and function description
>sp|Q7XA42|RGA1_SOLBU Putative disease resistance protein RGA1 OS=Solanum bulbocastanum GN=RGA1 PE=2 SV=2 Back     alignment and function description
>sp|Q7XA39|RGA4_SOLBU Putative disease resistance protein RGA4 OS=Solanum bulbocastanum GN=RGA4 PE=2 SV=1 Back     alignment and function description
>sp|Q7XA40|RGA3_SOLBU Putative disease resistance protein RGA3 OS=Solanum bulbocastanum GN=RGA3 PE=2 SV=2 Back     alignment and function description
>sp|Q7XBQ9|RGA2_SOLBU Disease resistance protein RGA2 OS=Solanum bulbocastanum GN=RGA2 PE=1 SV=1 Back     alignment and function description
>sp|O23530|SNC1_ARATH Protein SUPPRESSOR OF npr1-1, CONSTITUTIVE 1 OS=Arabidopsis thaliana GN=SNC1 PE=1 SV=3 Back     alignment and function description
>sp|Q38834|R13L4_ARATH Disease resistance RPP13-like protein 4 OS=Arabidopsis thaliana GN=RPP13L4 PE=2 SV=2 Back     alignment and function description
>sp|P23799|ESAG8_TRYBB Putative adenylate cyclase regulatory protein OS=Trypanosoma brucei brucei GN=ESAG8 PE=2 SV=1 Back     alignment and function description
>sp|Q5ZLN0|LRC40_CHICK Leucine-rich repeat-containing protein 40 OS=Gallus gallus GN=LRRC40 PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query861
356554923 1399 PREDICTED: putative disease resistance R 0.982 0.604 0.399 1e-163
284026888 1424 CC-NBS-LRR protein [Quercus suber] 0.984 0.595 0.398 1e-157
400131587 1388 FB_MR5 [Malus x robusta] 0.975 0.605 0.404 1e-154
147825318 1824 hypothetical protein VITISV_003723 [Viti 0.946 0.446 0.407 1e-146
225449959 1350 PREDICTED: putative disease resistance p 0.948 0.605 0.399 1e-144
224059590 1381 cc-nbs-lrr resistance protein [Populus t 0.969 0.604 0.380 1e-141
225449649 1418 PREDICTED: putative disease resistance p 0.958 0.581 0.383 1e-140
147775060 1330 hypothetical protein VITISV_014782 [Viti 0.952 0.616 0.398 1e-140
147846228 1372 hypothetical protein VITISV_006043 [Viti 0.969 0.608 0.398 1e-139
225449872 1322 PREDICTED: putative disease resistance p 0.951 0.619 0.400 1e-138
>gi|356554923|ref|XP_003545790.1| PREDICTED: putative disease resistance RPP13-like protein 1-like [Glycine max] Back     alignment and taxonomy information
 Score =  583 bits (1504), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 377/943 (39%), Positives = 539/943 (57%), Gaps = 97/943 (10%)

Query: 1    MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHR 60
            MED+G ++F++L + S FQ+SS + S +VMH LINDLAQW AG+  F++ +  + HK+ +
Sbjct: 464  MEDVGHEYFQELLSASLFQKSSSNRSLYVMHDLINDLAQWVAGESCFKLDNNFQSHKQKK 523

Query: 61   FSENL--RHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFK 118
               +   R+ SY+ G YDG++MF+   +AK LRTFLPL             H    +L +
Sbjct: 524  KKISKMTRYASYVGGEYDGIQMFQAFKEAKSLRTFLPLKHRRLEEWSYITNHVPFELLPE 583

Query: 119  LQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHR 178
            L+ LR LSL GY I  +P+S+ +L  L+YL+LS T ++ LPES+  L NL TLLL +C  
Sbjct: 584  LRCLRALSLSGYFISKLPNSVSNLNLLRYLNLSSTDLRQLPESICSLCNLQTLLLRDCFN 643

Query: 179  LKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLL 238
            L++L +NM  LI L HL  +   +L  MP GIG LTHL TLS FVVG    SG+  L  L
Sbjct: 644  LEELPSNMSDLINLRHLDITRSHSLTRMPHGIGKLTHLQTLSNFVVG---SSGIGELMKL 700

Query: 239  KHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTLMLDGL 298
             +++G L +S+LE+V D  EA EA + +K  +  L L+WTS  ++     E    +L  L
Sbjct: 701  SNIRGVLSVSRLEHVTDTREASEAMINKKVGIDVLKLKWTSCMNNQS-HTERAKEVLQML 759

Query: 299  KPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKHLFII 358
            +PH+NL +LTI+ YGGT+FP W+GD S+ +LV L+ + C  CTSLP++G L  LK L+II
Sbjct: 760  QPHKNLAKLTIKCYGGTSFPKWIGDPSYKSLVFLKLKDCAHCTSLPALGNLHALKELYII 819

Query: 359  EMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIG 418
             M  V  +  EF GN C  PFPSLE L F D+++WE W    + ++ ++F  L++L ++ 
Sbjct: 820  GMKEVCCIDGEFCGNACLRPFPSLERLYFMDMEKWENWFLSDNNEQNDMFSSLQQLFIVK 879

Query: 419  CPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCP 478
            CPKL G+LPE L SL+ ++V+ CEQL V +SSLP L KLEI GCKG+     N+ N    
Sbjct: 880  CPKLLGKLPENLPSLKHVIVKECEQLLVTISSLPVLYKLEIEGCKGLVLNCANEFNSLNS 939

Query: 479  Q-----------LLWLIAEEEQDQQQPVFPCSLQYLELSQC----RYLVKLPQALLSLGF 523
                        +  L+   +  ++  +  C+L    L+       +L K P  L S+  
Sbjct: 940  MSVSRILEFTFLMERLVQAFKTVEELKIVSCALDETVLNDLWVNEVWLEKNPHGLSSI-- 997

Query: 524  LREMEIYG-NLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSC 582
            LR +EI   N++K  SI       +  LE LYI  C S+   +  ++LP +L+ L + +C
Sbjct: 998  LRLIEIRNCNIMK--SIPKVLMVNSHFLERLYICHCDSIV-FVTMDQLPHSLKSLEISNC 1054

Query: 583  GNLAFL------------------------------------------SLVGNLPKALKY 600
             NL  L                                          S  G LP+++K+
Sbjct: 1055 KNLRCLLDNGTCTSSSIIMHDDNVQHGSTIISHLEYVYIGWCPSLTCISRSGELPESVKH 1114

Query: 601  ------------------------LSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVL 636
                                    L +  C KL+S+A RL  N+SLE+++I  CENL  L
Sbjct: 1115 LFIWNCSELSCLSMKGQLPKSIERLEIQSCPKLESIANRLHRNTSLESIQIWNCENLKSL 1174

Query: 637  PDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQE 696
            P+GL  L +L+EI I  CPNL+SFP+ G  +S+L++L I  CEKL ALPN M+NL SL+E
Sbjct: 1175 PEGLHFLVNLKEIKIIGCPNLVSFPEEGLPASSLSELSIMSCEKLVALPNSMYNLDSLKE 1234

Query: 697  LEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVS 756
            LEIG  PS+ YFPE  FP NL SL I D    +++  W  L + + LR L+I G    + 
Sbjct: 1235 LEIGYCPSIQYFPEINFPDNLTSLWINDHNACEAMFNW-GLYKLSFLRDLTIIGGN--LF 1291

Query: 757  FPQDNIGMMLPASLTKLEIVRFSNLEYLSSVG-ESLPSLECLILDDCPKLRYFPDKGLPP 815
             P + +G MLP++LT L +  F +LE LSS G   L SL  L + +CPKL   P+KGLP 
Sbjct: 1292 MPLEKLGTMLPSTLTSLTVQGFPHLENLSSEGFHKLTSLSKLSIYNCPKLLCLPEKGLPS 1351

Query: 816  SLLQLHISNCPLIEESCRKDGGQYWHLISDIPCVYINFRCVFD 858
            SLL+L+I +CP ++E CRKD G+ W  I+D+P V I+ + ++D
Sbjct: 1352 SLLELYIQDCPFLKEQCRKDKGRDWLKIADVPYVEIDGKFIYD 1394




Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|284026888|gb|ADB66335.1| CC-NBS-LRR protein [Quercus suber] Back     alignment and taxonomy information
>gi|400131587|emb|CCH50986.1| FB_MR5 [Malus x robusta] Back     alignment and taxonomy information
>gi|147825318|emb|CAN73260.1| hypothetical protein VITISV_003723 [Vitis vinifera] Back     alignment and taxonomy information
>gi|225449959|ref|XP_002271030.1| PREDICTED: putative disease resistance protein At3g14460-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|224059590|ref|XP_002299922.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222847180|gb|EEE84727.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|225449649|ref|XP_002262753.1| PREDICTED: putative disease resistance protein At3g14460 [Vitis vinifera] Back     alignment and taxonomy information
>gi|147775060|emb|CAN77204.1| hypothetical protein VITISV_014782 [Vitis vinifera] Back     alignment and taxonomy information
>gi|147846228|emb|CAN81660.1| hypothetical protein VITISV_006043 [Vitis vinifera] Back     alignment and taxonomy information
>gi|225449872|ref|XP_002265429.1| PREDICTED: putative disease resistance protein At3g14460 [Vitis vinifera] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query861
TAIR|locus:2091662 1424 AT3G14460 [Arabidopsis thalian 0.501 0.303 0.410 3.6e-102
TAIR|locus:20916721054 AT3G14470 [Arabidopsis thalian 0.500 0.408 0.378 1.3e-76
UNIPROTKB|O48647 1802 O48647 "XA1" [Oryza sativa (ta 0.817 0.390 0.262 7.6e-15
TAIR|locus:2094498 1981 AT3G25510 [Arabidopsis thalian 0.370 0.161 0.269 1.6e-19
TAIR|locus:2053405 1215 AT2G14080 [Arabidopsis thalian 0.442 0.313 0.266 1.6e-18
TAIR|locus:2163426 1187 TAO1 "target of AVRB operation 0.371 0.269 0.276 2.6e-18
TAIR|locus:2205824 1384 AT1G27170 [Arabidopsis thalian 0.585 0.364 0.25 2.5e-11
TAIR|locus:2147992 1189 AT5G11250 [Arabidopsis thalian 0.275 0.199 0.281 3.9e-13
TAIR|locus:2076043 1194 RPP1 "recognition of peronospo 0.340 0.245 0.273 2.7e-15
TAIR|locus:2098110 1219 AT3G44670 [Arabidopsis thalian 0.318 0.224 0.275 1.4e-12
TAIR|locus:2091662 AT3G14460 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 711 (255.3 bits), Expect = 3.6e-102, Sum P(2) = 3.6e-102
 Identities = 185/451 (41%), Positives = 237/451 (52%)

Query:     1 MEDLGRKFFRDLHAKSFFQQSSCDTSRFVMHHLINDLAQWAAGDIYFRMGDVLEDHKRHR 60
             +ED+G  +  DL A+SFFQ+     + FVMH L+NDLA+  +GD  FR    LED     
Sbjct:   458 LEDIGNDYLGDLVAQSFFQRLDITMTSFVMHDLMNDLAKAVSGDFCFR----LEDDNIPE 513

Query:    61 FSENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYMLFK-L 119
                  RHFS+ R   D    F  +  A+ LRT LP   S T      L   VL  L   L
Sbjct:   514 IPSTTRHFSFSRSQCDASVAFRSICGAEFLRTILPFN-SPTSLESLQLTEKVLNPLLNAL 572

Query:   120 QRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRL 179
               LR+LSL  Y I ++P S+  LK L+YLDLS TKIK LPE V  L NL TLLL NC  L
Sbjct:   573 SGLRILSLSHYQITNLPKSLKGLKLLRYLDLSSTKIKELPEFVCTLCNLQTLLLSNCRDL 632

Query:   180 KKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLK 239
               L  ++  LI L  L       L EMP GI  L  L  LS FV+G+  G+GL  LK L 
Sbjct:   633 TSLPKSIAELINLRLLDLVGTP-LVEMPPGIKKLRSLQKLSNFVIGRLSGAGLHELKELS 691

Query:   240 HLQGTLDISKLENVKDASEAKEAQLIEKRNXXXXXXEWTSSTSDDPMEHENVTL-----M 294
             HL+GTL IS+L+NV  ASEAK+A L  K        +WT   S       N        +
Sbjct:   692 HLRGTLRISELQNVAFASEAKDAGLKRKPFLDGLILKWTVKGSGFVPGSFNALACDQKEV 751

Query:   295 LDGLKPHRNLEELTIRGYGGTTFPTWMGDSSFANLVLLRFEGCHRCTSLPSVGQLPLLKH 354
             L  L+PH +L+   I  Y G  FP W+GDSSF  +  +    C+ C SLP VGQLP LK+
Sbjct:   752 LRMLEPHPHLKTFCIESYQGGAFPKWLGDSSFFGITSVTLSSCNLCISLPPVGQLPSLKY 811

Query:   355 LFIIEMTSVKMVGSEFY---GNHCSVPFPSLETLCFQDIQEWEGWI-PHGSGKEVNVFPQ 410
             L I +   ++ VG +F+    N   VPF SL+ L F  +  W+ WI P     E  +FP 
Sbjct:   812 LSIEKFNILQKVGLDFFFGENNSRGVPFQSLQILKFYGMPRWDEWICPE---LEDGIFPC 868

Query:   411 LRELSLIGCPKLQGRLPECLSSLERLVVRGC 441
             L++L +  CP L+ + PE L S   + +  C
Sbjct:   869 LQKLIIQRCPSLRKKFPEGLPSSTEVTISDC 899


GO:0005634 "nucleus" evidence=ISM
GO:0006952 "defense response" evidence=IEA;ISS
GO:0043531 "ADP binding" evidence=IEA
TAIR|locus:2091672 AT3G14470 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
UNIPROTKB|O48647 O48647 "XA1" [Oryza sativa (taxid:4530)] Back     alignment and assigned GO terms
TAIR|locus:2094498 AT3G25510 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2053405 AT2G14080 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2163426 TAO1 "target of AVRB operation1" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2205824 AT1G27170 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2147992 AT5G11250 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2076043 RPP1 "recognition of peronospora parasitica 1" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2098110 AT3G44670 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Your Input:
GSVIVG00028671001
SubName- Full=Chromosome chr13 scaffold_45, whole genome shotgun sequence; (1141 aa)
(Vitis vinifera)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query861
PLN03210 1153 PLN03210, PLN03210, Resistant to P 2e-13
PRK15386 426 PRK15386, PRK15386, type III secretion protein Gog 4e-04
PLN03210 1153 PLN03210, PLN03210, Resistant to P 6e-04
PLN03210 1153 PLN03210, PLN03210, Resistant to P 6e-04
PLN032101153 PLN03210, PLN03210, Resistant to P 0.001
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 0.001
COG4886394 COG4886, COG4886, Leucine-rich repeat (LRR) protei 0.002
>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P Back     alignment and domain information
 Score = 74.5 bits (183), Expect = 2e-13
 Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 12/195 (6%)

Query: 620 SSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECE 679
           ++LE +K+S C +L+ LP  +  LN L+++ +S C NL   P G  L S L +L +  C 
Sbjct: 657 TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKS-LYRLNLSGCS 715

Query: 680 KLKALPNGMHNLTSL--QELEIGDLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPL 737
           +LK+ P+   N++ L   E  I + PS +   E+     L   E++  K+W+ +    PL
Sbjct: 716 RLKSFPDISTNISWLDLDETAIEEFPSNLRL-ENLD--ELILCEMKSEKLWERVQPLTPL 772

Query: 738 NRFT--SLRRLSIHGCQDMVSFPQDNIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLE 795
                 SL RL +     +V  P     +     L  LEI    NLE L + G +L SLE
Sbjct: 773 MTMLSPSLTRLFLSDIPSLVELPSSIQNL---HKLEHLEIENCINLETLPT-GINLESLE 828

Query: 796 CLILDDCPKLRYFPD 810
            L L  C +LR FPD
Sbjct: 829 SLDLSGCSRLRTFPD 843


syringae 6; Provisional. Length = 1153

>gnl|CDD|237954 PRK15386, PRK15386, type III secretion protein GogB; Provisional Back     alignment and domain information
>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P Back     alignment and domain information
>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P Back     alignment and domain information
>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 861
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN032101153 Resistant to P. syringae 6; Provisional 99.97
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.96
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.95
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.95
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.94
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.93
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.92
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.92
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.92
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.9
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.89
KOG4237498 consensus Extracellular matrix protein slit, conta 99.72
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.63
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.62
KOG4237498 consensus Extracellular matrix protein slit, conta 99.6
KOG0617264 consensus Ras suppressor protein (contains leucine 99.54
KOG0617264 consensus Ras suppressor protein (contains leucine 99.49
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.48
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.47
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.39
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.18
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.15
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.95
KOG4341483 consensus F-box protein containing LRR [General fu 98.9
KOG4341483 consensus F-box protein containing LRR [General fu 98.86
KOG3207 505 consensus Beta-tubulin folding cofactor E [Posttra 98.74
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.7
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 98.68
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.66
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.65
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.6
PLN03150623 hypothetical protein; Provisional 98.6
PRK15386 426 type III secretion protein GogB; Provisional 98.55
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.54
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.54
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.53
PLN03150623 hypothetical protein; Provisional 98.47
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.46
PRK15386426 type III secretion protein GogB; Provisional 98.4
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 98.4
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 98.35
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 98.25
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.18
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 98.15
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.09
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.06
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.94
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 97.92
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 97.74
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.73
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.72
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.65
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.5
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.49
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 97.34
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.27
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.22
KOG1947482 consensus Leucine rich repeat proteins, some prote 97.15
KOG1947482 consensus Leucine rich repeat proteins, some prote 96.93
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 96.84
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.7
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 96.69
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 96.67
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.25
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 96.2
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.06
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 95.62
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 95.4
KOG0473326 consensus Leucine-rich repeat protein [Function un 95.36
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 94.97
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 94.93
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 94.65
KOG3864221 consensus Uncharacterized conserved protein [Funct 94.08
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 93.81
KOG0473326 consensus Leucine-rich repeat protein [Function un 92.96
smart0037026 LRR Leucine-rich repeats, outliers. 91.99
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 91.99
KOG3864221 consensus Uncharacterized conserved protein [Funct 91.91
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 87.52
smart0037026 LRR Leucine-rich repeats, outliers. 87.52
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
Probab=100.00  E-value=1.9e-43  Score=431.09  Aligned_cols=533  Identities=19%  Similarity=0.174  Sum_probs=335.5

Q ss_pred             CCceeEEEEEecCCCccchhhhhcccCCccEEeecccccCcCCcccchhhhhhc-cCCCCcccEEEccCccccc-cCccc
Q 038705           62 SENLRHFSYLRGGYDGLKMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYM-LFKLQRLRVLSLRGYSIFH-VPSSI  139 (861)
Q Consensus        62 ~~~~~~lsl~~~~~~~~~~~~~~~~~~~Lr~L~l~~~~~~~~~~~~~~~~~~~~-~~~l~~L~~L~L~~~~i~~-lp~~~  139 (861)
                      ..+++.+++.++.+... ....+..+++||+|.+.++.        +...+|.+ |..+++||+|+|++|.++. +|.  
T Consensus        68 ~~~v~~L~L~~~~i~~~-~~~~~~~l~~L~~L~Ls~n~--------~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--  136 (968)
T PLN00113         68 SSRVVSIDLSGKNISGK-ISSAIFRLPYIQTINLSNNQ--------LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--  136 (968)
T ss_pred             CCcEEEEEecCCCcccc-CChHHhCCCCCCEEECCCCc--------cCCcCChHHhccCCCCCEEECcCCccccccCc--
Confidence            45789999988876543 24678889999999886543        44578888 7799999999999999874 454  


Q ss_pred             CCCCccceeeccCCccc-ccchhhhccccccEEecCCccchhhchhhhhhccccceeecCCCcccccCcccccccccccc
Q 038705          140 GDLKHLQYLDLSETKIK-TLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKNSNVKALEEMPKGIGNLTHLLT  218 (861)
Q Consensus       140 ~~L~~L~~L~Ls~~~i~-~lp~~i~~L~~L~~L~l~~n~~~~~lp~~~~~L~~L~~L~l~~~~~~~~~p~~i~~l~~L~~  218 (861)
                      +.+++|++|+|++|.+. .+|..|+++++|++|++++|.+.+.+|..++++++|++|++++|.+.+.+|..++++++|++
T Consensus       137 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  216 (968)
T PLN00113        137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW  216 (968)
T ss_pred             cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccE
Confidence            56899999999999987 78888999999999999999888899999999999999999999988888999999999998


Q ss_pred             ccceEecccCCCCcccccccccccceeeecCccCCCChhHHHHHhhhcccCcchhheeeccCCCCCCcchhhHHHhhccc
Q 038705          219 LSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEKRNLLRLLLEWTSSTSDDPMEHENVTLMLDGL  298 (861)
Q Consensus       219 L~~~~~~~~~~~~~~~l~~l~~L~~~l~~~~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~l  298 (861)
                      |++..+...                              ...+..+..+.+|+.|++++|...+..          ...+
T Consensus       217 L~L~~n~l~------------------------------~~~p~~l~~l~~L~~L~L~~n~l~~~~----------p~~l  256 (968)
T PLN00113        217 IYLGYNNLS------------------------------GEIPYEIGGLTSLNHLDLVYNNLTGPI----------PSSL  256 (968)
T ss_pred             EECcCCccC------------------------------CcCChhHhcCCCCCEEECcCceecccc----------ChhH
Confidence            865443211                              011112344455555555554432211          1223


Q ss_pred             CCCCCccEEEEeecCCC-CCCcCCCCCCcCCeeEEEEeCCCCCCCCC-CCCCCCCcceeeeccccceeEECccccCCcCc
Q 038705          299 KPHRNLEELTIRGYGGT-TFPTWMGDSSFANLVLLRFEGCHRCTSLP-SVGQLPLLKHLFIIEMTSVKMVGSEFYGNHCS  376 (861)
Q Consensus       299 ~~~~~L~~L~l~~~~~~-~~p~~~~~~~~~~L~~L~L~~~~~~~~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~~~~~~~  376 (861)
                      ..+++|+.|++++|... .+|.++.  .+++|+.|++++|.+.+.+| .+..+++|+.|++++|.....++..+..    
T Consensus       257 ~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~----  330 (968)
T PLN00113        257 GNLKNLQYLFLYQNKLSGPIPPSIF--SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS----  330 (968)
T ss_pred             hCCCCCCEEECcCCeeeccCchhHh--hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhc----
Confidence            44455555555555432 3444442  25556666666665555555 4555556666666555433333222211    


Q ss_pred             CCCCCcceEeccccccccccccCCCCCcccccCccceEeccCCCCCcCCCCCCCCCcceEEEeccCCCcccCCCCCccce
Q 038705          377 VPFPSLETLCFQDIQEWEGWIPHGSGKEVNVFPQLRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCK  456 (861)
Q Consensus       377 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~~~~~~~L~~L~l~~c~~l~~~~p~~l~~L~~L~l~~~~~l~~~~~~~~~L~~  456 (861)
                        +++|+.|++++ +.+.+..+..+..    +++|+.|++++ +.+.+.+|..                  +..+++|+.
T Consensus       331 --l~~L~~L~L~~-n~l~~~~p~~l~~----~~~L~~L~Ls~-n~l~~~~p~~------------------~~~~~~L~~  384 (968)
T PLN00113        331 --LPRLQVLQLWS-NKFSGEIPKNLGK----HNNLTVLDLST-NNLTGEIPEG------------------LCSSGNLFK  384 (968)
T ss_pred             --CCCCCEEECcC-CCCcCcCChHHhC----CCCCcEEECCC-CeeEeeCChh------------------HhCcCCCCE
Confidence              44455555444 2333333322322    44455555554 2333333322                  112233333


Q ss_pred             EEEccCCCCcccccccccccccccchhhhhhhhhccCCCCCCcccEEEeecccccccchhhhhccccccEEEEecccccc
Q 038705          457 LEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKE  536 (861)
Q Consensus       457 L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~L~~L~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  536 (861)
                      +++++|......         +            ..+..+ ++|+.|++++|.+.+..|..+..+++|+.|++++|.  +
T Consensus       385 L~l~~n~l~~~~---------p------------~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l  440 (968)
T PLN00113        385 LILFSNSLEGEI---------P------------KSLGAC-RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN--L  440 (968)
T ss_pred             EECcCCEecccC---------C------------HHHhCC-CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCc--c
Confidence            333333211100         0            000011 255556666665555555555556666666666552  2


Q ss_pred             cccccccccCCCCccEEEecCCCCccccCCCCCCCCCccEEEEecCCCcccccccCCCcccCcEEeeccccCcchhhhhc
Q 038705          537 ESIQSSSTRYTSLLEYLYIDDCASLTSLLPKNELPATLEHLHVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERL  616 (861)
Q Consensus       537 ~~~~~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~~L~~L~l~~~~~l~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~  616 (861)
                      .......+..+++|+.|++++|                        .....+|..... ++|+.|++++|...+.+|..+
T Consensus       441 ~~~~~~~~~~l~~L~~L~L~~n------------------------~~~~~~p~~~~~-~~L~~L~ls~n~l~~~~~~~~  495 (968)
T PLN00113        441 QGRINSRKWDMPSLQMLSLARN------------------------KFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL  495 (968)
T ss_pred             cCccChhhccCCCCcEEECcCc------------------------eeeeecCccccc-ccceEEECcCCccCCccChhh
Confidence            2112222234455555555555                        322222211112 368888888887777778888


Q ss_pred             cCCCCccEEeeccccCcccccccccCCCCCcEEeeccCCCceecCCCCCCcCCccEEEeccccCcccccccCCCCCccCE
Q 038705          617 DNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQE  696 (861)
Q Consensus       617 ~~l~~L~~L~L~~~~~~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~  696 (861)
                      .++++|+.|++++|.+.+.+|..+.++++|++|++++|...+.+|..+..+++|+.|++++|++.+.+|..+.++++|+.
T Consensus       496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            88888888888888888888888888888888888888877788888888888888888888888888888888888888


Q ss_pred             EeecCCCCCcccCCCCCCCCccEEEecCcc
Q 038705          697 LEIGDLPSMVYFPEDGFPTNLHSLEIRDMK  726 (861)
Q Consensus       697 L~l~~n~~l~~~~~~~~~~~L~~L~l~~~~  726 (861)
                      |++++|+....+|..+.+.++....+.+|+
T Consensus       576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~  605 (968)
T PLN00113        576 VNISHNHLHGSLPSTGAFLAINASAVAGNI  605 (968)
T ss_pred             EeccCCcceeeCCCcchhcccChhhhcCCc
Confidence            888888777777766555555555555554



>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query861
4fcg_A328 Structure Of The Leucine-Rich Repeat Domain Of The 4e-05
>pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 Back     alignment and structure

Iteration: 1

Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust. Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%) Query: 598 LKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNL 657 L++ ++D L L + + LE + ++ L LP + LN L+E+ I CP L Sbjct: 106 LQHXTID-AAGLXELPDTXQQFAGLETLTLAR-NPLRALPASIASLNRLRELSIRACPEL 163 Query: 658 ISFP------DGGFLSSTLTKLWIYECE--KLKALPNGMHNLTSLQELEIGDLPSMVYFP 709 P D L L E +++LP + NL +L+ L+I + P P Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGP 223 Query: 710 EDGFPTNLHSLEIRDMKMWKSLIEWEPL-NRFTSLRRLSIHGCQDMVSFPQDNIGMMLPA 768 +L LE D++ +L + P+ L+RL + C ++++ P D + Sbjct: 224 AI---HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT--- 277 Query: 769 SLTKLEIVRFSNLEYLSSVGESLPSLECLIL 799 L KL++ NL L S+ LP+ C+IL Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPA-NCIIL 307

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query861
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 6e-22
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 2e-21
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 5e-20
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 1e-18
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 2e-16
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 3e-16
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 4e-15
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 2e-13
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 3e-09
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 1e-07
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 2e-04
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-15
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 5e-15
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 5e-14
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 9e-13
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-10
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-08
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-07
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 1e-05
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-12
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 2e-06
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 1e-05
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 4e-05
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 5e-12
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-07
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 3e-04
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 8e-12
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 1e-11
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-09
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-09
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 8e-07
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 6e-06
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 1e-05
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 7e-05
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-11
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 6e-11
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-10
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 3e-08
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 4e-08
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-06
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-06
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 2e-05
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 2e-11
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 6e-10
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 6e-07
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-11
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 3e-10
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 3e-09
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 3e-07
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 1e-06
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 5e-06
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 1e-04
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 4e-04
1o6v_A466 Internalin A; bacterial infection, extracellular r 1e-10
1o6v_A466 Internalin A; bacterial infection, extracellular r 1e-06
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-04
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-04
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 2e-10
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 5e-08
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 2e-04
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-10
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 7e-06
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 8e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-10
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 2e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-04
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-10
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-08
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-06
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-04
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 7e-10
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 9e-10
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 2e-09
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 5e-07
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 6e-06
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 6e-06
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-05
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-09
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 4e-09
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-09
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-08
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-07
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 7e-07
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 4e-06
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-04
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-09
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-09
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-09
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-05
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 4e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 4e-08
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-04
4fmz_A347 Internalin; leucine rich repeat, structural genomi 5e-09
4fmz_A347 Internalin; leucine rich repeat, structural genomi 6e-06
4fmz_A347 Internalin; leucine rich repeat, structural genomi 7e-05
1z6t_A591 APAF-1, apoptotic protease activating factor 1; ca 5e-09
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 6e-09
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 3e-08
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-06
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 3e-04
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-04
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-08
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 8e-07
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 6e-06
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-04
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-08
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-07
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 9e-07
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-04
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 6e-08
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 6e-07
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 1e-05
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 1e-05
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 2e-05
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 3e-05
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 8e-05
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 7e-08
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 5e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-06
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 6e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 8e-08
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 4e-05
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 5e-05
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 7e-05
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 8e-04
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-07
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 6e-04
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-07
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 4e-06
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 6e-06
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 2e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 3e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 9e-04
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 2e-07
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 4e-04
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 2e-07
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-04
4ezg_A197 Putative uncharacterized protein; internalin-A, le 8e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 1e-04
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-04
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-06
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 2e-04
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-06
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 8e-04
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 9e-04
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 3e-06
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 6e-04
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 3e-06
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 3e-06
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 4e-05
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 4e-06
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 1e-05
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 4e-05
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 7e-05
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 8e-05
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 4e-06
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-05
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 2e-04
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 9e-04
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 6e-06
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-05
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-05
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 2e-05
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 4e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 2e-05
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 4e-05
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 2e-05
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 2e-05
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 1e-04
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 3e-05
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 1e-04
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 3e-04
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 6e-04
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 4e-05
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 2e-04
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 4e-04
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 7e-05
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 1e-04
3e6j_A229 Variable lymphocyte receptor diversity region; var 1e-04
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 1e-04
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 1e-04
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-04
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 3e-04
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 4e-04
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 5e-04
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 4e-04
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 5e-04
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 6e-04
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
 Score = 96.9 bits (242), Expect = 6e-22
 Identities = 62/325 (19%), Positives = 96/325 (29%), Gaps = 62/325 (19%)

Query: 411 LRELSLIGCPKLQGRLPECLSSLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRST 470
              L   G   L+    + LS  +R                      +I           
Sbjct: 14  RENLYFQGSTALR-PYHDVLSQWQRHYNA-DRNRWHSAWRQANSNNPQI----------- 60

Query: 471 NDVNRCCPQLLWLIAEEEQDQQQPVFPCSLQYLELSQCRYLVKLPQALLSLGFLREMEIY 530
               R    L       E   Q          LEL     L + P     L  L+ M I 
Sbjct: 61  --ETRTGRALKATADLLEDATQP-----GRVALELRSVP-LPQFPDQAFRLSHLQHMTID 112

Query: 531 GNLIKE--ESIQS---------SSTRYTSL---------LEYLYIDDCASLTSL---LPK 567
              + E  +++Q          +     +L         L  L I  C  LT L   L  
Sbjct: 113 AAGLMELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 568 NELPATLEHLHVKSCGNLAFLSLVGN----LP------KALKYLSVDHCLKLKSLAERLD 617
            +     + L      NL  L L       LP      + LK L + +   L +L   + 
Sbjct: 173 TDASGEHQGLV-----NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNS-PLSALGPAIH 226

Query: 618 NNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNLISFPDG-GFLSSTLTKLWIY 676
           +   LE + +  C  L   P        L+ + +  C NL++ P     L+  L KL + 
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ-LEKLDLR 285

Query: 677 ECEKLKALPNGMHNLTSLQELEIGD 701
            C  L  LP+ +  L +   + +  
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPP 310


>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>1z6t_A APAF-1, apoptotic protease activating factor 1; caspase activation, ADP, nucleotide binding, CARD, apoptosis; HET: ADP; 2.21A {Homo sapiens} Length = 591 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query861
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 100.0
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 100.0
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 100.0
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 100.0
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 100.0
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 100.0
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.98
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.97
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.97
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.97
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.97
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.96
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.95
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.95
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.95
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.94
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.94
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.93
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.92
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.92
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.92
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.92
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.92
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.91
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.91
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.89
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.89
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.89
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.88
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.86
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.85
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.84
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.84
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.84
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.83
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.82
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.82
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.82
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.81
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.81
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.81
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.81
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.81
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.81
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.8
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.8
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.8
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.78
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.78
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.78
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.76
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.76
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.75
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.75
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.74
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.74
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.73
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.73
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.71
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.7
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.7
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.69
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.69
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.67
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.67
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.67
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.66
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.65
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.64
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.63
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.63
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.63
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.63
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.6
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.57
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.56
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.54
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.54
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.53
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.52
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.51
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.5
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.49
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.47
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.47
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.46
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.45
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.45
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.44
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.43
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.41
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.4
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.4
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.39
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.38
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.38
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.37
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.36
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.36
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.35
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.35
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.34
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.32
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.32
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.29
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.28
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.26
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.24
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.21
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.21
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.2
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.19
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.18
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.18
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.17
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.14
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.11
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.1
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.07
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.07
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.05
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.99
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.93
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.9
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.85
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.76
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.75
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.54
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.52
4gt6_A394 Cell surface protein; leucine rich repeats, putati 98.48
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.41
4gt6_A394 Cell surface protein; leucine rich repeats, putati 98.37
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.22
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.22
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 98.14
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 98.13
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.13
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.09
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 98.06
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.99
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.92
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 97.91
2a5y_B549 CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis 97.09
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 96.63
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.85
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.67
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 93.76
3sfz_A1249 APAF-1, apoptotic peptidase activating factor 1; a 90.99
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 83.2
1z6t_A591 APAF-1, apoptotic protease activating factor 1; ca 82.13
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
Probab=100.00  E-value=3.8e-55  Score=518.82  Aligned_cols=665  Identities=16%  Similarity=0.084  Sum_probs=353.5

Q ss_pred             HHHHhccceEEecccccCccccCCCCceeEEEEEecCCCcc--chhhhhcccCCccEEeecccccCcCCcccchhhhhhc
Q 038705           38 AQWAAGDIYFRMGDVLEDHKRHRFSENLRHFSYLRGGYDGL--KMFEVLSDAKRLRTFLPLVLSNTWSGKAYLAHSVLYM  115 (861)
Q Consensus        38 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lsl~~~~~~~~--~~~~~~~~~~~Lr~L~l~~~~~~~~~~~~~~~~~~~~  115 (861)
                      +.|.+...|+.+.+.     .++ .++++.+++.+..+...  ...+++.++++|+.+.+..+.         ...+|+.
T Consensus        31 ~~W~~~~~~C~w~gv-----~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~---------~~~l~~~   95 (768)
T 3rgz_A           31 PDWSSNKNPCTFDGV-----TCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSH---------INGSVSG   95 (768)
T ss_dssp             TTCCTTSCGGGSTTE-----EEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSC---------EEECCCC
T ss_pred             cCCCCCCCCcCCcce-----EEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCC---------cCCCchh
Confidence            445444555555431     122 56788888877654421  023566677777777653321         1234456


Q ss_pred             cCCCCcccEEEccCcccc-ccCc--ccCCCCccceeeccCCccc-ccchhh-hccccccEEecCCccchhhchhh---hh
Q 038705          116 LFKLQRLRVLSLRGYSIF-HVPS--SIGDLKHLQYLDLSETKIK-TLPESV-NKLWNLHTLLLENCHRLKKLCAN---MG  187 (861)
Q Consensus       116 ~~~l~~L~~L~L~~~~i~-~lp~--~~~~L~~L~~L~Ls~~~i~-~lp~~i-~~L~~L~~L~l~~n~~~~~lp~~---~~  187 (861)
                      |.++++|++|+|++|.++ .+|.  .++++++|++|+|++|.+. .+|..+ +++++|++||+++|.+.+..|..   ++
T Consensus        96 ~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~  175 (768)
T 3rgz_A           96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD  175 (768)
T ss_dssp             CCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTT
T ss_pred             hccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhc
Confidence            888888888888888876 4566  7888888888888888876 555554 78888888888888776766666   67


Q ss_pred             hccccceeecCCCcccccCccccccccccccccceEecccCCCCcccccccccccceeeecCccCCCChhHHHHHhhhcc
Q 038705          188 SLIKLHHLKNSNVKALEEMPKGIGNLTHLLTLSRFVVGKDVGSGLRTLKLLKHLQGTLDISKLENVKDASEAKEAQLIEK  267 (861)
Q Consensus       188 ~L~~L~~L~l~~~~~~~~~p~~i~~l~~L~~L~~~~~~~~~~~~~~~l~~l~~L~~~l~~~~l~~~~~~~~~~~~~l~~~  267 (861)
                      ++++|++|++++|.+.+..|  ++++++|++|++..+.....  +..                             +..+
T Consensus       176 ~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~--~~~-----------------------------l~~l  222 (768)
T 3rgz_A          176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG--IPF-----------------------------LGDC  222 (768)
T ss_dssp             CCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSC--CCB-----------------------------CTTC
T ss_pred             cCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCC--Ccc-----------------------------cccC
Confidence            88888888888888555444  37777888776654432211  111                             3344


Q ss_pred             cCcchhheeeccCCCCCCcchhhHHHhhcccCCCCCccEEEEeecCCC-CCCcCCCCCCcCCeeEEEEeCCCCCCCCC-C
Q 038705          268 RNLLRLLLEWTSSTSDDPMEHENVTLMLDGLKPHRNLEELTIRGYGGT-TFPTWMGDSSFANLVLLRFEGCHRCTSLP-S  345 (861)
Q Consensus       268 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~~p~~~~~~~~~~L~~L~L~~~~~~~~~~-~  345 (861)
                      ++|++|++++|...+.          ....+..+++|++|++++|... .+|.+    .+++|++|++++|.+.+.+| .
T Consensus       223 ~~L~~L~Ls~n~l~~~----------~~~~l~~l~~L~~L~Ls~n~l~~~~~~~----~l~~L~~L~L~~n~l~~~ip~~  288 (768)
T 3rgz_A          223 SALQHLDISGNKLSGD----------FSRAISTCTELKLLNISSNQFVGPIPPL----PLKSLQYLSLAENKFTGEIPDF  288 (768)
T ss_dssp             CSCCEEECCSSCCCSC----------HHHHTTTCSSCCEEECCSSCCEESCCCC----CCTTCCEEECCSSEEEESCCCC
T ss_pred             CCCCEEECcCCcCCCc----------ccHHHhcCCCCCEEECCCCcccCccCcc----ccCCCCEEECcCCccCCccCHH
Confidence            5555555555443221          1223455566666666666543 22322    36677777777777665555 3


Q ss_pred             CCC-CCCcceeeeccccceeEECccccCCcCcCCCCCcceEeccccccccccccCC-CCCcccccCccceEeccCCCCCc
Q 038705          346 VGQ-LPLLKHLFIIEMTSVKMVGSEFYGNHCSVPFPSLETLCFQDIQEWEGWIPHG-SGKEVNVFPQLRELSLIGCPKLQ  423 (861)
Q Consensus       346 l~~-l~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~l~~~~~~~-~~~~~~~~~~L~~L~l~~c~~l~  423 (861)
                      +.. +++|++|++++|.....++..+..      +++|++|++++ +.+.+..+.. +..    +++|++|++++ +.++
T Consensus       289 ~~~~~~~L~~L~Ls~n~l~~~~p~~~~~------l~~L~~L~L~~-n~l~~~ip~~~l~~----l~~L~~L~Ls~-n~l~  356 (768)
T 3rgz_A          289 LSGACDTLTGLDLSGNHFYGAVPPFFGS------CSLLESLALSS-NNFSGELPMDTLLK----MRGLKVLDLSF-NEFS  356 (768)
T ss_dssp             SCTTCTTCSEEECCSSEEEECCCGGGGG------CTTCCEEECCS-SEEEEECCHHHHTT----CTTCCEEECCS-SEEE
T ss_pred             HHhhcCcCCEEECcCCcCCCccchHHhc------CCCccEEECCC-CcccCcCCHHHHhc----CCCCCEEeCcC-CccC
Confidence            444 377777777766554444444332      66777777776 3444333222 333    67777777777 3565


Q ss_pred             CCCCCCCC----CcceEEEeccCCCcccCCCCCccceEEEccCCCCcccccccccccccccchhhhhhhhhccCCC-CCC
Q 038705          424 GRLPECLS----SLERLVVRGCEQLTVLVSSLPKLCKLEIGGCKGMAWRSTNDVNRCCPQLLWLIAEEEQDQQQPV-FPC  498 (861)
Q Consensus       424 ~~~p~~l~----~L~~L~l~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~  498 (861)
                      +.+|..+.    +|+.|+++++.........                                          +.. ..+
T Consensus       357 ~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~------------------------------------------~~~~~~~  394 (768)
T 3rgz_A          357 GELPESLTNLSASLLTLDLSSNNFSGPILPN------------------------------------------LCQNPKN  394 (768)
T ss_dssp             ECCCTTHHHHTTTCSEEECCSSEEEEECCTT------------------------------------------TTCSTTC
T ss_pred             ccccHHHHhhhcCCcEEEccCCCcCCCcChh------------------------------------------hhhcccC
Confidence            56665432    3444444433211000000                                          000 003


Q ss_pred             cccEEEeecccccccchhhhhccccccEEEEecccccccccccccccCCCCccEEEecCCCCccccCCCC-CCCCCccEE
Q 038705          499 SLQYLELSQCRYLVKLPQALLSLGFLREMEIYGNLIKEESIQSSSTRYTSLLEYLYIDDCASLTSLLPKN-ELPATLEHL  577 (861)
Q Consensus       499 ~L~~L~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~l~~~~~~~-~~~~~L~~L  577 (861)
                      +|++|++++|.+.+.+|..+..+++|+.|++++|  .+.......+..+++|++|++++|. +...++.. ..++     
T Consensus       395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N--~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~~~~l~-----  466 (768)
T 3rgz_A          395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN--YLSGTIPSSLGSLSKLRDLKLWLNM-LEGEIPQELMYVK-----  466 (768)
T ss_dssp             CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSS--EEESCCCGGGGGCTTCCEEECCSSC-CCSCCCGGGGGCT-----
T ss_pred             CccEEECCCCccccccCHHHhcCCCCCEEECcCC--cccCcccHHHhcCCCCCEEECCCCc-ccCcCCHHHcCCC-----
Confidence            5666666666666666666666666666666666  2222222223455566666666653 22211111 1122     


Q ss_pred             EEecCCCcccccccCCCcccCcEEeeccccCcchhhhhccCCCCccEEeeccccCcccccccccCCCCCcEEeeccCCCc
Q 038705          578 HVKSCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGLLKLNHLQEIFISHCPNL  657 (861)
Q Consensus       578 ~l~~~~~l~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~~~l~~L~~L~L~~~~~~  657 (861)
                                         +|++|++++|...+.+|..+..+++|++|++++|.+.+.+|..+..+++|++|++++|...
T Consensus       467 -------------------~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  527 (768)
T 3rgz_A          467 -------------------TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS  527 (768)
T ss_dssp             -------------------TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             -------------------CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCccc
Confidence                               3444444444333333444444444444444444444444444444444444444444333


Q ss_pred             eecCCCCCCcCCccEEEeccccCcccccccCCCCCccCEE----------------------------------------
Q 038705          658 ISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQEL----------------------------------------  697 (861)
Q Consensus       658 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L----------------------------------------  697 (861)
                      +.+|..+..+++|+.|++++|++.+.+|..+.....+..+                                        
T Consensus       528 ~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  607 (768)
T 3rgz_A          528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL  607 (768)
T ss_dssp             EECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGG
T ss_pred             CcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcc
Confidence            3444433344444444444444444443333222222111                                        


Q ss_pred             ------eecCCCCCcccCCC-CCCCCccEEEecCccCcccccccccCCcCCCcCeEEeecCCCccccCCCcccCcCCCCc
Q 038705          698 ------EIGDLPSMVYFPED-GFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQDNIGMMLPASL  770 (861)
Q Consensus       698 ------~l~~n~~l~~~~~~-~~~~~L~~L~l~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~~~~L  770 (861)
                            ++..+..-..+|.. ..+++|+.||+++|++.+.+|..  ++.+++|+.|++++|...+.+|....   -+++|
T Consensus       608 ~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~--l~~l~~L~~L~Ls~N~l~g~ip~~l~---~L~~L  682 (768)
T 3rgz_A          608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE--IGSMPYLFILNLGHNDISGSIPDEVG---DLRGL  682 (768)
T ss_dssp             GGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG--GGGCTTCCEEECCSSCCCSCCCGGGG---GCTTC
T ss_pred             ccccccccccceecccCchhhhccccccEEECcCCcccccCCHH--HhccccCCEEeCcCCccCCCCChHHh---CCCCC
Confidence                  11111111111111 22455666666666666555554  56666666666666655555555432   22455


Q ss_pred             cEEEeccCCCCcccccCCCCCCCCCEEeccCCCCcccCCCCCCccccceeeccCCcchHH----HHhccCCccccccccC
Q 038705          771 TKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQLHISNCPLIEE----SCRKDGGQYWHLISDI  846 (861)
Q Consensus       771 ~~L~l~~~~~l~~l~~~~~~~~~L~~L~l~~c~~l~~~~~~~~~~sL~~L~l~~c~~l~~----~~~~~~~~~~~~~~~~  846 (861)
                      +.|+++++.--..++.....+++|+.|++++|+--+.+|..+.+.++....+.+||.++-    .|....+.+|++++|+
T Consensus       683 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~~~~~~~~~~~  762 (768)
T 3rgz_A          683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS  762 (768)
T ss_dssp             CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC----------
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCCccCCCCCCCCc
Confidence            555555543333344334778889999999997777888877777787788888876542    5999999999999999


Q ss_pred             ceEE
Q 038705          847 PCVY  850 (861)
Q Consensus       847 ~~v~  850 (861)
                      +.++
T Consensus       763 ~~~~  766 (768)
T 3rgz_A          763 HHHH  766 (768)
T ss_dssp             ----
T ss_pred             cccC
Confidence            9775



>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>2a5y_B CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis elegans} SCOP: a.4.5.80 a.77.1.3 c.37.1.20 PDB: 3lqq_A* 3lqr_A* Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Back     alignment and structure
>1z6t_A APAF-1, apoptotic protease activating factor 1; caspase activation, ADP, nucleotide binding, CARD, apoptosis; HET: ADP; 2.21A {Homo sapiens} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 861
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 3e-06
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 8e-04
d1dcea3124 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase 1e-04
d1a9na_162 c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom 6e-04
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 8e-04
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 8e-04
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.004
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]
 Score = 47.7 bits (112), Expect = 3e-06
 Identities = 42/247 (17%), Positives = 86/247 (34%), Gaps = 8/247 (3%)

Query: 581 SCGNLAFLSLVGNLPKALKYLSVDHCLKLKSLAERLDNNSSLEAVKISYCENLIVLPDGL 640
            C +L    +  +LP     L + +    +       N  +L  + +   +   + P   
Sbjct: 16  QCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 641 LKLNHLQEIFISHCPNLISFPDGGFLSSTLTKLWIYECEKLKALPNGMHNLTSLQELEIG 700
             L  L+ +++S    L   P+   +  TL +L ++E E  K   +  + L  +  +E+G
Sbjct: 76  APLVKLERLYLSKN-QLKELPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132

Query: 701 DLPSMVYFPEDGFPTNLHSLEIRDMKMWKSLIEWEPLNRFTSLRRLSIHGCQDMVSFPQD 760
             P      E+G    +  L    +      I   P     SL  L + G +        
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTN--ITTIPQGLPPSLTELHLDGNKITKVDAAS 190

Query: 761 NIGMMLPASLTKLEIVRFSNLEYLSSVGESLPSLECLILDDCPKLRYFPDKGLPPSLLQL 820
             G+    +L KL +   S     +    + P L  L L++   ++          +  +
Sbjct: 191 LKGLN---NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247

Query: 821 HISNCPL 827
           ++ N  +
Sbjct: 248 YLHNNNI 254


>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query861
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.85
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.81
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.81
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.79
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.79
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.78
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.73
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.66
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.66
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.65
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.61
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.61
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.46
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.46
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.44
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.44
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.42
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.41
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.39
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.38
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.35
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.34
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.33
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.33
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.3
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.29
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.27
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.25
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.24
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.18
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.1
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.92
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.85
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.8
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.75
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.55
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.1
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.0
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 97.13
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 96.59
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.35
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 95.65
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85  E-value=5.3e-20  Score=197.59  Aligned_cols=80  Identities=18%  Similarity=0.298  Sum_probs=65.5

Q ss_pred             CCCcccEEEccCccccccCcccCCCCccceeeccCCcccccchhhhccccccEEecCCccchhhchhhhhhccccceeec
Q 038705          118 KLQRLRVLSLRGYSIFHVPSSIGDLKHLQYLDLSETKIKTLPESVNKLWNLHTLLLENCHRLKKLCANMGSLIKLHHLKN  197 (861)
Q Consensus       118 ~l~~L~~L~L~~~~i~~lp~~~~~L~~L~~L~Ls~~~i~~lp~~i~~L~~L~~L~l~~n~~~~~lp~~~~~L~~L~~L~l  197 (861)
                      .+.+|++|+++++.|+.+ +.+..+++|++|++++|+|+.+|. |+++++|++|++++|.+. .++ .++.+++|+.|++
T Consensus        42 ~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~-~i~-~l~~l~~L~~L~~  117 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL  117 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEEC
T ss_pred             HhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence            456788999999988887 468888999999999999988864 889999999999988644 343 3888889999998


Q ss_pred             CCCc
Q 038705          198 SNVK  201 (861)
Q Consensus       198 ~~~~  201 (861)
                      +++.
T Consensus       118 ~~~~  121 (384)
T d2omza2         118 FNNQ  121 (384)
T ss_dssp             CSSC
T ss_pred             cccc
Confidence            8887



>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure